Rapid on-site evaluation using telecytology: Quality assurance study at a high-volume cancer center
- PMID: 39745134
- PMCID: PMC12135963
- DOI: 10.1002/cncy.22929
Rapid on-site evaluation using telecytology: Quality assurance study at a high-volume cancer center
Abstract
Background: Telecytology-assisted rapid on-site evaluation (ROSE) offers a cost-effective method to enhance minimally invasive biopsies like fine needle aspiration and core biopsies with touch preparation. By reducing nondiagnostic sampling and the need for repeat procedures, ROSE via telecytology facilitates prompt triage for ancillary tests, improving patient management. This study examines cases initially deemed adequate for diagnosis during telecytology-assisted ROSE but later categorized as nondiagnostic at final evaluation (NDIS).
Design: We performed a retrospective analysis of telecytology-assisted ROSE cases over 7 years at a major cancer center, focusing on fine needle aspiration and touch preparation of core biopsies. Each case was thoroughly reviewed, correlating with clinical data and concurrent core biopsies or subsequent excisions. The study identified leading factors contributing to NDIS.
Results: The average NDIS rate was 0.06% (42/70,612). Misinterpretation of benign or reactive cells as neoplastic was the leading cause (76.2%) of discrepancies between original ROSE and final diagnosis. Kidney biopsies had the highest NDIS rate (0.90%), primarily because of misinterpreting nonneoplastic cells. Thyroid biopsies were linked to quantitative threshold issues (0.10%). NDIS events were most associated with misinterpretation in kidney, pancreas, gastrointestinal tract, and lung biopsies.
Conclusion: In conclusion, the NDIS rate in telecytology-assisted ROSE is low, but quality assurance identified areas for improvement. Recognizing site-specific pitfalls during telecytology-assisted ROSE can enhance diagnostic accuracy and optimize patient care.
Keywords: cytology; nondiagnostic interpretation of specimens; quality assurance; rapid on‐site evaluation; telecytology.
© 2024 American Cancer Society.
Conflict of interest statement
Figures





Similar articles
-
Rapid on-site evaluation using telecytology: A major cancer center experience.Diagn Cytopathol. 2019 Jan;47(1):15-19. doi: 10.1002/dc.23925. Epub 2018 Mar 25. Diagn Cytopathol. 2019. PMID: 29575752 Free PMC article.
-
Rapid on-site evaluation of fine-needle aspiration specimens using cytotechnologist-performed telecytology: Insights and advantages.Cytopathology. 2025 Jan;36(1):2-11. doi: 10.1111/cyt.13428. Epub 2024 Aug 19. Cytopathology. 2025. PMID: 39158137 Review.
-
Rapid On-Site Evaluation With Telecytology Significantly Reduced Unsatisfactory Rates of Thyroid Fine-Needle Aspiration.Am J Clin Pathol. 2020 Feb 8;153(3):342-345. doi: 10.1093/ajcp/aqz164. Am J Clin Pathol. 2020. PMID: 31628844
-
Current landscape and emerging opportunities for using telecytology for rapid on-site assessment in cytopathology.Cancer Cytopathol. 2025 Jul;133(7):e70027. doi: 10.1002/cncy.70027. Cancer Cytopathol. 2025. PMID: 40522771 Free PMC article. Review.
-
American Society of Cytopathology Telecytology validation recommendations for rapid on-site evaluation (ROSE).J Am Soc Cytopathol. 2024 Mar-Apr;13(2):111-121. doi: 10.1016/j.jasc.2023.12.001. Epub 2023 Dec 9. J Am Soc Cytopathol. 2024. PMID: 38310002 Review.
References
-
- Lin DM, Tracht J, Rosenblum F, et al. Rapid On-Site Evaluation With Telecytology Significantly Reduced Unsatisfactory Rates of Thyroid Fine-Needle Aspiration. Am J Clin Pathol. 2020;153:342–345. - PubMed
-
- Witt BL, Schmidt RL. Rapid onsite evaluation improves the adequacy of fine-needle aspiration for thyroid lesions: a systematic review and meta-analysis. Thyroid. 2013;23:428–435. - PubMed
-
- Schmidt RL, Witt BL, Lopez-Calderon LE, Layfield LJ. The influence of rapid onsite evaluation on the adequacy rate of fine-needle aspiration cytology: a systematic review and meta-analysis. Am J Clin Pathol. 2013;139:300–308. - PubMed
-
- Monaco SE, Koah AE, Xing J, et al. Telecytology implementation: Deployment of telecytology for rapid on-site evaluations at an Academic Medical Center. Diagn Cytopathol. 2019;47:206–213. - PubMed
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Medical